Abstract
The production of cytokines in human skin in vivo has been investigated and found to be more selective than studies in vitro have suggested. Thus, stratum corneum samples from the skin lesions of psoriasis contain interleukin 8 (IL-8)-like material, but assay for a range of other compounds suggested that no other defined, biologically active cytokine was present in increased levels when compared with those in control heel stratum corneum samples. Selective cytokine release was also found on analysis of chamber fluid samples from the skin lesions of the cutaneous T-cell lymphoma, mycosis fungoides. Assay of normal epidermal samples has shown the presence of biologically active amounts of IL-1 like material, chromatographic purification and the use of neutralizing antibodies indicating the presence of IL-1α but negligible IL-1β activity in normal heel stratum corneum extracts. No other biologically active cytokine has been detected in normal skin. The IL-1α-like material recoverable from normal human epidermis possesses potent inflammatory properties when injected intradermally, but appears not to be biologically available under normal in vivo conditions, possibly through intracellular retention in keratinocytes, membrane association or control by an inhibitor. The release of preformed IL-1 following membrane perturbation or other events may constitute a primary mechanism for the induction of inflammation in human skin. For reasons to be outlined below, IL-1 may be less important in the maintenance of chronic inflammatory changes, at least in psoriasis, IL-8 possibly playing a more significant role.
Keywords
- High Performance Liquid Chromatography
- Stratum Corneum
- Normal Skin
- Mycosis Fungoides
- Intradermal Injection
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Brain, S.D., R.D.R. Camp, F.M. Cunningham, P.M. Dowd, M.W. Greaves, and A. Kobza Black. 1984. Leukotriene B4-like material in scale of psoriatic skin lesions. Br. J. Pharmacol. 83: 313–317.
Brain, S.D., R.D.R. Camp, P.M. Dowd, A. Kobza Black, and M.W. Greaves. 1984. The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis. J. Invest. Dermatol. 83: 70–73.
WooUard, P.M. 1986. Stereochemical difference between 12-hydroxy-5,8,10,14-eicosatetraenoic acid in platelets and psoriatic lesions. Biochem. Biophys. Res. Commun. 136: 169–176.
Mallet, A.I., and F.M. Cunningham. 1985. Structural identification of platelet activating factor in psoriatic scale. Biochem. Biophys. Res. Commun. 126: 192–198.
Schröder, J.M., and E. Christophers. 1986. Identification of C5a des arg and an anionic neutrophil activating peptide (ANAP) in psoriatic scales. J. Invest. Dermatol. 87: 53–58.
Camp, R.D.R., N.J. Fincham, F.M. Cunningham, M.W.Greaves, J. Morris, and A.C. Chu. 1986. Psoriasis skin lesions contain biologically active amounts of an interleukin 1-like compound. J. Immunol. 137: 3469–3474.
Fincham, N.J., R.D.R. Camp, AJ.H. Gearing, C.R. Bird, and F.M. Cunningham. 1988. Neutrophil chemoattractant and IL-1-like activity in samples from psoriatic skin lesions. Further characterisation. J. Immunol. 140: 4294–4299.
Gearing, A.J.H., N.J. Fincham, C.R. Bird, A.M. Wadhwa, A. Meager, J.E. Cartwright, and Camp R.D.R. 1990. Cytokines in skin lesions of psoriasis. Cytokine. 2: 68–75.
Schröder, J.M., and E. Christophers. 1989. Amino acid sequence characterization of two ultrastructurally related neutrophil activating peptides obtained from lesional psoriatic scales. J. Invest. Dermatol. 92: 515(abstract).
Grossman, R,M., J. Krueger, D. Yourish, A. Granelli-Piperno, D.P. Murphy, L.T. May, T.S. Kupper, P.B. Seghai, A.B. Gottlieb. 1989. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci. USA. 86: 6367–6371.
Prens E.P., J. van Damme, M. Bakkus, K. Brakel, R. Benner, and T. van Joost. 1989. IL-1 and IL-6 in psoriasis. J. invest. Dermatol. 93: 570 (abstract).
Larsen, C.G., A.O. Anderson, E. Appella, J.J. Oppenheim, and K. Matsushima, 1989. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science. 243: 1464–1466.
Bacon, K.B., J. Westwick, and R.D.R. Camp. 1989. Potent and specific inhibition of IL-8-, IL-Iα- and IL-1β-induced lymphocyte migration by calcium channel antagonists. Biochem. Biophys. Res. Commun. 165: 349–354.
Krueger, G., C. Jorgensen, C. Miller, J. Schröder, M. Sticherling, and E. Christophers. 1990. Effects of IL-8 on epidermal proliferation. J. Invest. Dermatol. 94: 545 (abstract).
Barker, J.N.W.N., V. Sharma, R.S. Mitra, V.M. Dixit, and B.J. Nickoloff. 1990. Marked synergism between tumour necrosis factor-α and interferon-in regulating keratinocyte-derived adhesion molecules and chemotactic factors.J. Clin. Invest. 85: 606–608.
Barker, J.N.W.N., M.L. Jones, C. Swenson, R.S. Mitra, J.T.Elder, J.C. Fantone, P.A. Ward, V.M. Dixit, and B.J. Nickoloff. 1990. Keratinocyte (KC) production of a biologically active monocyte chemoattractant. J. Invest. Dermatol. 94: 505 (abstract).
Schröder, J.M., M. Sticherling, H.H. Heneicke, W.C. Preissner, and E. Christophers, 1990. IL-1 or tumour necrosis factor-α stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J.Immunol. 144: 2223–2232.
Schröder, J.M., and E. Christophers. 1990. Determination of IL-8-related cytokines in the stratum corneum of chronic as well as acute inflammatory skin diseases. J. Invest. Dermatol. (abstract in press).
Leonard E.J., A. Skeel, T. Yoshimura, K.Noer, S. Kutvirt, and D. van Epps. 1990. Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. J.Immunol. 144: 1323–1330.
Bacon, K.B., and R.D.R. Camp. 1989. Calcium channel antagonists inhibit leukotriene (LT)B4 and interleukin(IL) 1α-induced lymphocyte migration. Skin Pharmacol. 2: 47 (abstract).
Bacon, K.B., and R.D.R. Camp. 1990. Interleukin (IL)-8-induced in vitro human lymphocyte migration is inhibited by cholera and pertussis toxins and inhibitors of protein kinase C. Biochem. Biophys. Res. Commun., in press.
Leonard, E., T. Yoshimura, S. Tanaka, and M. Raffeld. 1989. Neutrophil infiltration caused by intradermal injection of neutrophil attractant protein-1 (NAP-1/IL-8)into human skin. Cytokine 1: 151 (abstract).
Quinn, D.G., and R.D.R. Camp. 1990. Novel monocyte attractants in stratum corneum from psoriatic lesions. J. Invest. Dermatol. 94: 569 (abstract).
Lawlor, F., N.P. Smith, R.D.R. Camp, K.B. Bacon, A. Kobza-Black, M.W. Greaves, and A.J.H. Gearing. 1990. Skin exudate levels of interleukin 6, interleukin-1, and other cytokines in mycosis fungoides. Br. J. Dermatol. in press.
Dowd, P., B.A. Hudspith, R.M. Barr, and J.A. Miller. 1987. Release in vivo of interleukin-1 (IL-1)-like activity by human skin. Clin. Exp. Immunol. 67: 608–610.
Tron, V.A., D. Rosenthal, and D.N. Sauder. 1988. Epidermal interleukin-1 is increased in cutaneous T-cell lymphoma. J. Invest. Dermatol. 90: 373–381.
Bacon, K., A. Gearing, and R. Camp. 1990. Induction of in vitro human lymphocyte migration by interleukin 3, interleukin 4, and interleukin 6. Cytokine. 2: 100–105.
Gahring, L.C., A. Buckley, and R.A. Daynes. 1985.Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum. J. Clin. Invest. 76: 1585–1591.
Hauser, G., J.H. Saurat, A. Schmitt, F. Jaunin and J.M. Dayer. 1986. Interleukin 1 is present in normal human epidermis. J. Immunol. 136: 3317–3323.
Camp, R., N. Fincham, J. Ross, C. Bird, and A. Gearing. 1990. Potent inflammatory properties in human skin of interleukin-1α-like material isolated from normal skin. J. Invest. Dermatol. 94: 735–741.
Granstein, R.D., R. Margolis and S.B. Mizel. 1986. In vivo inflammatory activity of epidermal cell-derived thymocyte activating factor and recombinant interleukin 1 in the mouse. J. Clin. Invest. 77: 1020–1027.
De Young, L.M., D.A. Spires, J. Kheifets, and T.G. Terrell. 1987. Biology and pharmacology of recombinant human interleukin-1β-induced rat ear inflammation. Agents and Actions. 21: 325–327.
Rampart, M., and T.J. Williams. 1988. Evidence that neutrophil accumulation induced by interleukin-1 requires both local protein synthesis and neutrophil CD18 antigen expression in vitro. Br. J. Pharmacol. 94: 1143–1148.
Dowd, P.M., R.D.R. Camp, and M.W. Greaves. 1988. Human recombinant interleukin-1α is proinflammatory in normal skin. Skin Pharmacol. 1: 30–37.
Kupper, T.S., D.W. Ballard, A.O. Chua, J.S. McGuire, P.M.Flood, M.W. Horowitz, R. Langdon, L. Lightfoot, and U. Gubler. 1986. Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1α and β mRNA. J. Exp. Med. 164: 2095–2100.
Reitamo, S,. H.S.I. Antilla, L. Didierjean, J-H. Saurat. 1990. Immunohistochemical identification of interleukin 1α and β in human eccrine sweat-gland apparatus. Br. J. Dermatol. 122: 315–323.
Georgilis, K., C. Schaefer, C.A. Dinarello. and M.S. Klempner. 1987. Human recombinant interleukin 1β has no effect on intracellular calcium or on functional responses of human neutrophils. J. Immunol. 138: 3403–3407.
Yoshimura, T., K. Matsushima, J.J. Oppenheim, and E.J. Leonard. 1987. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterisation and separation from interleukin 1 (IL-1). J. Immunol. 139: 12788–793.
Westmacott, D., J. Wadsworth, and D.P. Bloxham. 1987. Chemotactic activity of recombinant human interleukin 1. Agents and Actions. 21: 323–324.
Maloff, B.L., J.E. Shaw, and D. Fox. 1988. A Chemotaxis assay using human polymorphonuclear leukocytes stimulated by IL-1. J. Immunol. Methods. 112: 145–146.
Parker, K.P., W.R. Benjamin, K.L. Kafka, and P.L. Kilian. 1989. Presence of IL-1 receptors on human and murine neutrophils. Relevance to IL-1-mediated affects in inflammation. J. Immunol. 142: 537–542.
Ross, J.S., K.B. Bacon, and R.D.R. Camp. 1990. Potent and selective inhibition of in vitro lymphocyte migration by cyclosporin and dexamethasone. Immunopharmacol. Immunotoxicol. 12: in press.
Hunninghake, G.W., A.J. Glazier, M.M. Monick, and C.A.Dinarello. 1987. Interleukin 1 is a chemotactic factor for human T-lymphocytes. Am. Rev. Resp. Dis. 135: 66–71.
Miossec, P., C-L. Yu, and M. Ziff. 1984. Lymphocyte chemotactic activity of human interleukin 1. J. Immunol. 133: 2007–2011.
Rossi, V., F. Brevario, P. Ghezzi, E. Dejana, and A. Mantovani. 1985. Prostacyclin synthesis induced in vascular cells by interleukin 1. Science. 229: 174–176.
Bussolini, F., F. Brevario, C. Tetta, M. Aglietta, A. Mantovani, and E. Dejana. 1986. Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells. J. Clin. Invest. 77: 2027–2033.
Beasley, D., R.A. Cohen, and N.G. Levinsky. 1989. Interleukin 1 inhibits contraction of vascular smooth muscle. J. Clin. Invest. 83: 331–335.
Bacon, K.B., R.D.R. Camp, F.M. Cunningham, and P.M. Woollard. 1988. Contrasting in vitro chemotactic activity of the hydroxyl enantiomers of 12-hydroxy-5,8,10,14-eicosatetraenoic acid. Br. J. Pharmacol. 95: 966–975.
Bacon, K.B., N.J. Fincham, and R.D.R. Camp. 1990. Stimulation of lymphocyte migration by a novel low molecular weight compound in normal skin and plasma. Eur. J. Immunol. 20: 565–571.
Zigmond, S.H., and J.G. Hirsch. 1973. Leukocyte locomotion and Chemotaxis. J. Exp. Med. 137: 387–410.
Kornfeld, H., J.S. Berman, D.J. Beer. and D.M. Center.1985. Induction of human T lymphocyte motility by interleukin 2. J. Immunol. 137: 3887–3890.
Robbins, R.A., L. Klassen, J. Rasmussen, M.E.M. Clayton, and W.D. Russ. 1986. Interleukin-2-induced Chemotaxis of human T-lymphocytes. J. Lab. Clin. Med. 108: 340–345.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Camp, R. et al. (1991). Chemotactic Cytokines in Inflammatory Skin Disease. In: Westwick, J., Lindley, I.J.D., Kunkel, S.L. (eds) Chemotactic Cytokines. Advances in Experimental Medicine and Biology, vol 305. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-6009-4_13
Download citation
DOI: https://doi.org/10.1007/978-1-4684-6009-4_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-6011-7
Online ISBN: 978-1-4684-6009-4
eBook Packages: Springer Book Archive